3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase NA
5
Phase 1/2
3
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Myelodysplastic Syndromes
16
Leukemia
11
Multiple Myeloma
10
Lymphoma, Non-Hodgkin
9
Leukemia, Myelomonocytic, Chronic
9
Hodgkin Disease
9
Lymphoma
8
Anemia, Refractory, with Excess of Blasts
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Leukemia, Myeloid, Chronic-Phase
6
Graft vs Host Disease
6
Congenital Abnormalities
6
Primary Myelofibrosis
5
Myeloproliferative Disorders
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Neoplasms, Plasma Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, B-Cell, Marginal Zone
4
Hematologic Neoplasms
4
Burkitt Lymphoma
4
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, Large-Cell, Anaplastic
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Interventions
Cyclophosphamide
5
fludarabine
3
Clofarabine
3
thymoglobulin
2
fludarabine phosphate
2
Vorinostat
2
Polymerase Chain Reaction
2
Methotrexate
2
Isotretinoin
2
Gemtuzumab
2
Flow Cytometry
2
Busulfan
2
Azacitidine
2
Antilymphocyte Serum
2
tipifarnib
1
ruxolitinib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
cc-486
1
Whole-Body Irradiation
1
Topotecan
1
Thiotepa
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Radioimmunotherapy
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Mycophenolic Acid
1
MK 2206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myelomonocytic, Juvenile
×
Mycophenolic Acid
×
Clear all
NCT00669890
2015-04-22
High Risk
New York Medical College
Phase 1
Terminated
12 enrolled